TRIENTINE-RZ trientine dihydrochloride 250 mg capsule bottle

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

trientine dihydrochloride, Quantity: 250 mg

Dostępny od:

Dr Reddys Laboratories Australia Pty Ltd

Forma farmaceutyczna:

Capsule

Skład:

Excipient Ingredients: magnesium stearate; titanium dioxide; macrogol 3350; Gelatin; iron oxide yellow; purified water; colloidal anhydrous silica

Droga podania:

Oral

Sztuk w opakowaniu:

100

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

Trientine dihydrochloride capsules are indicated for the treatment of patients with Wilson's disease who are intolerant of penicillamine.

Podsumowanie produktu:

Visual Identification: Yellow opaque, hard gelatin size 1 capsules imprinted with RDY on cap and 459 on body in black ink filled with white to pale yellow powder.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status autoryzacji:

Registered

Data autoryzacji:

2021-03-29